Margot S Peters

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. doi Dermatopathology of the female breast
    Margot S Peters
    Mayo Clinic College of Medicine, Rochester, MN, USA
    Am J Dermatopathol 35:289-304; quiz 305-7. 2013
  2. doi Cutaneous extramedullary plasmacytoma: clinical, prognostic, and interphase cytogenetic analysis
    Nneka I Comfere
    Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Dermatopathol 35:357-63. 2013
  3. doi Atypical generalized eruptive histiocytosis clonally related to chronic myelomonocytic leukemia with loss of Y chromosome
    Wonwoo Shon
    Department of Dermatology, Mayo Clinic, Rochester, MN, USA
    J Cutan Pathol 40:725-9. 2013
  4. doi Margin comments in dermatopathology reports on dysplastic nevi influence re-excision rates
    Nneka I Comfere
    Department of Dermatology, Mayo Clinic, Rochester, Minnesota Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota Electronic address
    J Am Acad Dermatol 69:687-92. 2013
  5. doi Bullous dermatitis artefacta
    Olayemi Sokumbi
    Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Dermatopathol 35:110-2. 2013
  6. doi Favorable long-term outcomes in patients with histologically dysplastic nevi that approach a specimen border
    Thomas L Hocker
    Department of Dermatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Am Acad Dermatol 68:545-51. 2013
  7. doi Pharmacogenetics in dermatology: a patient-centered update
    Nneka I Comfere
    Department of Dermatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Int J Dermatol 52:1005-12. 2013
  8. doi Decreased expression of intercellular adhesion molecules in acantholytic squamous cell carcinoma compared with invasive well-differentiated squamous cell carcinoma of the skin
    John R Griffin
    Dept of Dermatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Am J Clin Pathol 139:442-7. 2013
  9. doi BRAF mutation-positive folliculotropic metastatic melanoma
    Katherine E Brick
    Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Dermatopathol 35:609-12. 2013

Collaborators

Detail Information

Publications9

  1. doi Dermatopathology of the female breast
    Margot S Peters
    Mayo Clinic College of Medicine, Rochester, MN, USA
    Am J Dermatopathol 35:289-304; quiz 305-7. 2013
    ..Our data and the literature indicate that few disorders specifically affect breast skin, but the nipple-areola complex should be approached with a different set of diagnostic considerations...
  2. doi Cutaneous extramedullary plasmacytoma: clinical, prognostic, and interphase cytogenetic analysis
    Nneka I Comfere
    Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Dermatopathol 35:357-63. 2013
    ..Our findings raise questions about the relative prognostic value of molecular aberrations observed in cEMP and PCM. The role of fluorescence in situ hybridization testing in predicting disease progression of cEMP remains to be defined...
  3. doi Atypical generalized eruptive histiocytosis clonally related to chronic myelomonocytic leukemia with loss of Y chromosome
    Wonwoo Shon
    Department of Dermatology, Mayo Clinic, Rochester, MN, USA
    J Cutan Pathol 40:725-9. 2013
    ..Discovery of additional cases may shed further light on the pathogenesis of this rare entity. ..
  4. doi Margin comments in dermatopathology reports on dysplastic nevi influence re-excision rates
    Nneka I Comfere
    Department of Dermatology, Mayo Clinic, Rochester, Minnesota Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota Electronic address
    J Am Acad Dermatol 69:687-92. 2013
    ..Dermatopathology reports influence clinical management, but it is not clear to what extent comments on margin involvement of histopathologically dysplastic nevi (HDN) influence decisions about re-excision or complete excision...
  5. doi Bullous dermatitis artefacta
    Olayemi Sokumbi
    Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Dermatopathol 35:110-2. 2013
    ..These 2 patients highlight the importance of histopathology in confirming a diagnosis of bullous dermatitis artefacta...
  6. doi Favorable long-term outcomes in patients with histologically dysplastic nevi that approach a specimen border
    Thomas L Hocker
    Department of Dermatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Am Acad Dermatol 68:545-51. 2013
    ..Patients with multiple clinically dysplastic nevi are at increased risk for development of melanoma. However, the risk of melanoma arising in a histologically dysplastic nevus (HDN) is unknown...
  7. doi Pharmacogenetics in dermatology: a patient-centered update
    Nneka I Comfere
    Department of Dermatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Int J Dermatol 52:1005-12. 2013
    ..Despite dramatic advances, wide application of pharmacogenetics to clinical practice has been slow for a number of reasons, including lack of evidence-based therapeutic guidelines as well as ethical concerns and cost...
  8. doi Decreased expression of intercellular adhesion molecules in acantholytic squamous cell carcinoma compared with invasive well-differentiated squamous cell carcinoma of the skin
    John R Griffin
    Dept of Dermatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Am J Clin Pathol 139:442-7. 2013
    ..Differences in expression of adhesion markers between ASCC and SCC may contribute to the development of acantholysis in ASCC and its more aggressive biologic behavior...
  9. doi BRAF mutation-positive folliculotropic metastatic melanoma
    Katherine E Brick
    Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Dermatopathol 35:609-12. 2013
    ....